Acute Hip Fracture Study in Patients 65 Years or Greater

NCT02578095 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

108

Enrollment

INDUSTRY

Sponsor class

Conditions

Hip Fractures

Interventions

DRUG: VK5211
DRUG: Placebo

Sponsor

Viking Therapeutics, Inc.